< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 10 days · First seen · Last updated

PT Swayasa Prakarsa Tbk IPO process

Overview

PT Swayasa Prakarsa Tbk, a medical device manufacturer affiliated with Universitas Gadjah Mada (UGM), initially planned to launch an Initial Public Offering (IPO) on the Indonesia Stock Exchange. The company aimed to raise up to Rp45.22 billion by offering 323 million new shares, with a target price range of Rp130 to Rp140 per share. The proceeds were intended for working capital, capital expenditures, and settling obligations to PT Gama Multi Usaha Mandiri and the Universitas Gadjah Mada Foundation.

However, the company subsequently postponed the IPO. The Indonesia Stock Exchange confirmed that the postponement followed a formal request on September 1, 2026. The delay was attributed to the company not yet receiving an effective statement from the Financial Services Authority (OJK) and the expiration of the financial statements used for the offering process on August 31, 2026.

Entities

Universitas Gadjah Mada · PT Sukadana Prima Sekuritas · PT Swayasa Prakasa Tbk · Indonesia Stock Exchange · Bursa Efek Indonesia

Timeline

  1. 9 days ago

    [BUSINESS] 2 sources
    PT Swayasa Prakarsa Tbk postpones IPO on Indonesia Stock Exchange

    PT Swayasa Prakarsa Tbk has postponed its IPO on the Indonesia Stock Exchange because it has not yet received the necessary effective statement from the OJK.

  2. 19 days ago

    [BUSINESS] 2 sources
    PT Swayasa Prakasa Tbk targets Rp45.22 billion in upcoming IPO

    PT Swayasa Prakasa Tbk, a subsidiary of UGM's holding company, plans an IPO to raise up to Rp45.22 billion, targeting a listing on the Indonesia Stock Exchange by September 10, 2026.

Sources

antaranews.com · cnbcindonesia.com · katadata.co.id · pemilu2024.harianjogja.com